• SENSEX 80,242.24
    -46.14 (--0.06%)
  • BANKNIFTY 55,087.15
    -304.10 (--0.55%)
  • Reliance Industr
    1,411.85 1,608.95(%)
  • Mazagon Dock
    3,149.70 3,149.70(%)
  • Bajaj Finance
    8,560.00 6,376.55(%)
  • Garden Reach Sh.
    1,855.00 890.05(%)
  • Cochin Shipyard
    1,575.50 1,169.00(%)
  • Tata Motors
    641.10 542.55(%)
  • Hind.Aeronautics
    4,466.00 3,045.95(%)
  • Paras Defence
    1,469.00 1,592.75(%)
  • Torrent Pharma.
    3,300.00 2,513.05(%)
  • Sonata Software
    446.50 762.00(%)
  • Data Pattern
    2,450.00 1,350.50(%)
  • IndusInd Bank
    843.10 1,550.00(%)
  • Samvardh. Mothe.
    131.75 107.30(%)
  • Bharat Electron
    312.50 221.00(%)
  • Trent
    5,130.00 4,197.50(%)
  • Varun Beverages
    507.45 419.40(%)
  • ICICI Bank
    1,415.10 1,051.50(%)
  • Vedanta
    423.20 527.00(%)
  • Hitachi Energy
    14,879.00 16,534.50(%)
  • Tech Mahindra
    1,510.60 1,807.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Zenith Drugs Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 92356.0
  • ISIN : INE0QWN01013
79.50 -2 (-2.27%)
  • As on 30 Apr 2025 (EOD)

  • Today’s Low

    78.00

  • Today’s High

    81.35

  • Open

    78.05

  • Perv Close

    81.35

  • 52W Low

    47.15

  • 52W High

    154.40

Key Indicators

  • P/E(TTM)

    12.91

  • Mar.Cap (₹Cr.)

    136.33

  • Div & Yield %

    0.63

  • Book Value(₹)

    36.28

  • Debt-Equity Ratio

    -2.27

  • AGM Date

    30-Apr-2025

  • EPS

    6.16

  • P/E Ratio

    12.91

Financials Ratios

  • Debt-Equity Ratio

    0.63

  • Mar.Cap (₹Cr.)

    136.33

  • RONW (%)

    24.13

  • ROCE (%)

    25.16

Score Board

  • Equity (₹ in Cr.)

    17.15

  • BV (₹)

    36.30

  • Sales( ₹ in Cr.)

    131.62

  • NP (in Cr.)

    10.57

  • NP Var(%)

    117.0

  • Div%

    5.0

  • CPS (₹)

    6.90

  • EPS (₹)

    6.20

  • Traded Value (₹ in Lakhs)

    139.51

  • 52 Week High

    154.40

  • 52 Week Low

    47.15

  • Price BSE

    0.0

  • Price NSE

    81.00

  • Market Capital( in Cr.)

    139.51

  • P/C Ratio

    11.70

  • P/E Ratio

    13.10

  • Price Vs.BV

    6.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 131.62 114.52 101.62 81.12 85.94 -
Excise Duty 0.00 0.00 9.97 7.72 7.67 -
Net Sales 131.62 114.52 91.65 73.40 78.27 -
Other Income 2.12 1.24 0.95 0.11 0.06 -
Stock Adjustments -1.36 0.54 2.93 -0.16 -0.38 -
Total Income 132.38 116.30 95.53 73.35 77.95 -
EXPENDITURE :            
Raw Materials 0.00 0.00 69.19 47.69 53.64 -
Power and Fuel Cost 1.09 1.04 0.00 0.00 0.03 -
Employee Cost 6.09 4.96 2.98 2.41 3.00 -
Other Manufacturing Expenses 90.95 84.63 6.33 4.84 3.55 -
Selling and Administration Expenses 0.00 0.00 9.13 10.95 9.84 -
Miscellaneous Expenses 16.66 15.38 0.03 0.16 0.79 -
Employee Benefit Expenses 6.09 4.96 2.98 2.41 3.00 -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 -
Total Expenses 114.79 106.01 87.66 66.05 70.85 -
Operating Profit 17.59 10.29 7.88 7.31 7.11 -
Interest 3.00 2.33 2.14 1.49 1.31 -
Gross Profit 14.59 7.96 5.74 5.82 5.80 -
Depreciation 1.30 1.30 1.34 1.22 0.92 -
Profit Before Tax 13.29 6.66 4.40 4.60 4.88 -
Current Tax 3.99 1.83 1.24 1.36 1.51 -
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 -
Deferred Tax -0.24 -0.05 -0.05 0.17 -0.04 -
Reported Net Profit 9.54 4.88 3.21 3.07 3.40 -
Extraordinary Items -1.03 0.00 0.00 0.00 0.01 -
Adjusted Net Profit 10.57 4.88 3.21 3.07 3.39 -
Adjustment below Net Profit -9.54 -4.88 0.00 0.00 0.00 -
P & L Balance brought forward 0.00 0.00 9.04 5.97 2.57 -
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 -
Appropriations 0.00 0.00 0.00 0.00 0.00 -
P & L Balance carried down 0.00 0.00 12.25 9.04 5.97 -
Dividend 0.00 0.00 0.00 0.00 0.00 -
Preference Dividend 0.00 0.00 0.00 0.00 0.00 -
Equity Dividend (%) 5.00 0.00 0.00 0.00 0.00 -
Dividend Per Share(Rs) 0.50 0.00 0.00 0.00 0.00 -
Earnings Per Share-Unit Curr 5.56 122.03 80.32 76.66 85.00 -
Earnings Per Share(Adj)-Unit Curr 5.56 - - - - -
Book Value 36.28 443.30 321.27 240.95 164.29 -
Book Value(Adj)-Unit Curr 36.28 - - - - -

Shareholding Pattern

  • Promoter Group

    69.98%

  • Public Share Holding

    30.02%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 12,000,000 69.98 12,000,000 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 12,000,000 69.98 12,000,000 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 72,000 0.42 72,000 4
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 72,000 0.42 72,000 4
2] Non Institution
Bodies Corporate 300,800 1.75 300,800 21
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 169,600 0.99 169,600 38
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,387,200 8.09 1,387,200 21
Individuals holding nominal share capital up to Rs. 1 lakh 2,998,400 17.48 2,998,400 1,197
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 220,800 1.29 220,800 67
Sub Total 5,076,800 29.60 5,076,800 1,344
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 17,148,800 100.00 17,148,800 1,355

Company Background

Zenith Drugs LtdPharmaceuticals - Indian - Formulations

  • Zenith Drugs Ltd
  • BSE Code : 92356.0
  • ISIN : INE0QWN01013

  • Incorporation Year

    2000

  • Registered Office

    K # 72/5 Village Muradpura
    NA Depalpur, Indore,
    Madhya Pradesh-453001

  • Telephone

    +91 84355 01867

  • FAX

  • Chairman

  • Managing Director

    Sandeep Bhardwaj

  • Company Secretary

    Sakshi Bhawsar

  • Auditor

    VDS & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No 56-2 ,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Zenith Drugs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Zenith 79.50 133.74 131.62 14.30 27.46
Abbott India 29,876.95 6,097.18 5,848.91 47.58 44.71
Astrazeneca Phar 8,665.50 1,330.33 1,295.53 223.40 33.26
P & G Health Ltd 5,072.65 1,166.89 1,151.26 35.59 39.76
Glaxosmi. Pharma 2,959.45 3,530.73 3,407.25 58.85 44.44
Cipla 1,549.65 17,645.00 16,574.34 26.57 20.10
Amrutanjan Healt 692.80 437.58 421.23 40.61 20.84
Guj. Themis Bio. 272.65 174.19 169.82 56.45 44.82
Fermenta Biotec. 260.70 315.24 307.09 24.71 4.10
Bliss GVS Pharma 119.00 638.96 605.46 27.23 11.19
Ambalal Sarabhai 36.46 11.70 3.81 15.58 1.92